Navigoe Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31K Buy
63
+3
+5% +$1.44K 0.02% 108
2026
Q1
$29K Hold
60
0.02% 91
2025
Q4
$34K Sell
60
-3
-5% -$1.7K 0.02% 91
2025
Q3
$30K Sell
63
-2
-3% -$931 0.02% 94
2025
Q2
$26K Hold
65
0.02% 87
2025
Q1
$32K Sell
65
-7
-10% -$3.79K 0.03% 76
2024
Q4
$37K Buy
+72
New +$39.6K 0.04% 72

Other funds holding TMO

Navigoe Wealth Management's TMO Position: Q2 2026 in Review

Navigoe Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 5% in Q2 2026, buying an estimated $1.44K and bringing the position to 63 shares worth $31K. The position accounts for 0.02% of the portfolio, ranked #108.

Navigoe Wealth Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $37K in Q4 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Navigoe Wealth Management held 63 shares of Thermo Fisher Scientific worth $31K as of Q2 2026.
  • Navigoe Wealth Management bought 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.02% of Navigoe Wealth Management's portfolio in Q2 2026, its #108 holding.
  • Navigoe Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Navigoe Wealth Management's Thermo Fisher Scientific position peaked at $37K in Q4 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Navigoe Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.